<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0022">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <string-name>
    <surname>Lou</surname>
    <given-names>PH</given-names>
   </string-name>, 
   <string-name>
    <surname>Lucchinetti</surname>
    <given-names>E</given-names>
   </string-name>, 
   <string-name>
    <surname>Zhang</surname>
    <given-names>L</given-names>
   </string-name>, 
   <string-name>
    <surname>Affolter</surname>
    <given-names>A</given-names>
   </string-name>, 
   <string-name>
    <surname>Schaub</surname>
    <given-names>MC</given-names>
   </string-name>, 
   <string-name>
    <surname>Gandhi</surname>
    <given-names>M</given-names>
   </string-name>, 
   <string-name>
    <surname>Hersberger</surname>
    <given-names>M</given-names>
   </string-name>, 
   <string-name>
    <surname>Warren</surname>
    <given-names>BE</given-names>
   </string-name>, 
   <string-name>
    <surname>Lemieux</surname>
    <given-names>H</given-names>
   </string-name>, 
   <string-name>
    <surname>Sobhi</surname>
    <given-names>HF</given-names>
   </string-name>, 
   <etal>et al.</etal>
  </person-group>
  <year>2014</year>
  <article-title>The mechanism of Intralipid
   <sup>®</sup>-mediated cardioprotection complex IV inhibition by the active metabolite, palmitoylcarnitine, generates reactive oxygen species and activates reperfusion injury salvage kinases
  </article-title>. 
  <source>PLoS One</source>. 
  <volume>9</volume>(
  <issue>1</issue>):
  <fpage>e87205</fpage>.
  <pub-id pub-id-type="pmid">24498043</pub-id>
 </mixed-citation>
</ref>
